Concomitant inactivation of p53 and Chk2 in breast cancer-Reference-Cited by-同舟云学术

Concomitant inactivation of p53 and Chk2 in breast cancer

Published:2002-02 Issue:9 Volume:21 Page:1316-1324
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Sullivan Alexandra,Yuille Martin,Repellin Claire,Reddy Archana,Reelfs Olivier,Bell Alexandra,Dunne Barbara,Gusterson Barry A,Osin Peter,Farrell Paul J,Yulug Isik,Evans Abigail,Ozcelik Tayfun,Gasco Milena,Crook Tim

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1205207.pdf

Reference27 articles.

1. Acquati F, Morelli C, Cinquetti R, Bianchi MG, Porrini D, Varesco L, Gismondi V, Rocchetti R, Talevi S, Possati L, Magnanini C, Tibilett MG, Bernasconi B, Daidone MG, Shridhar V, Smith DI, Negrini M, Barbanti-Brodano G, Taramelli R . 2001 Oncogene 20: 980–988

2. Allinen M, Huusko P, Mantyniemi S, Launonen V, Winqvist R . 2001 Br. J. Cancer 85: 209–212

3. Banelli B, Casciano I, Romani M . 2000 Oncogene 19: 4553–4556

4. Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J . 2001 Oncogene 20: 5897–5902

5. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA . 1999 Science 286: 2528–2531

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the DNA damage response pathway in the infected gastric tissue with Helicobacter pylori: a case-control study;The Journal of Infection in Developing Countries;2023-08-31

2. Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside;Biomedicine & Pharmacotherapy;2023-02

3. The Chk2-PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer;Oncogene;2021-07-09

4. Epigenetic changes in FOXO3 and CHEK2 genes and their correlation with clinicopathological findings in myelodysplastic syndromes;Hematology/Oncology and Stem Cell Therapy;2020-12

5. Immunohistochemistry analysis of checkpoint kinase 2 in oral squamous cell carcinoma;Applied Cancer Research;2020-03-18